Healthcare – Page 6 – Latest Market Trends

Personal Care Packaging Market Will Reach Height of USD 37.25 billion By 2025

Robust growth in the personal care & cosmetic industry is attributed to growing awareness about individual health and safety, increasing personal disposable income and improved lifestyle mainly in developed economies.

The global Personal Care Packaging Market size is expected to value at USD 37.25 billion by 2022. The market is subject to witness a substantial growth due to the soaring need for environment friendly and sustainable packaging solutions for cosmetics and personal care products. Robust growth in the personal care & cosmetic industry is attributed to growing awareness about individual health and safety, increasing personal disposable income and improved lifestyle mainly in developed economies.

Shift in customer preference towards organic cosmetics alongside large-scale consummation of sustainable products are expanding the market reach of the personal care packaging in near future. Globally, the personal care packaging industry is predicted to grow at higher CAGR in the forecast period, providing numerous opportunities for market players to invest for research and development in the packaging industry.

Request Sample Copy of This Market Research @

https://www.millioninsights.com/industry-reports/personal-care-packaging-market/request-sample

The recent technological advancement in the personal care & cosmetics industry coupled with development of advanced packaging solution are anticipated to boost market growth over the forecast period. In addition, growing manufacturing sector in South East Asian economies such as Singapore, South Korea, Taiwan and Malaysia is projected to escalate the growth of personal care packaging market in upcoming years. Rigid plastic packaging currently holds a higher market share in the personal care packaging.

Increasing adoption of the rigid plastic packaging materials is credited to their lightweight and eco-friendly nature, thus rocketing the demand of rigid plastic packaging in personal care packaging industry, in the recent years. Additionally, metal, glass and paper can be easily recycled for multiple use due to their flexibility. These factors are responsible for enlarged demands of rigid plastic in the market of personal care packaging. Other factors such as ease of use, simple operation and cost-effectiveness are complementing the market demand, in recent years.

Browse Full Research Report @

https://www.millioninsights.com/industry-reports/personal-care-packaging-market

Paper and glass packaging solutions are gaining traction in personal care packaging market due to their biodegradable properties. Paper and glass packaging is ideal substitute for plastics in packaging & manufacturing of personal care products. These factors are largely influencing the market growth, thus creating lucrative opportunities for industry players during this period. Furthermore, increasing consumer awareness about environmental hazards with excessive use of plastic and complete ban on the use of the lightweight plastic materials in few countries are expected to amplify the growth of glass and paper packaging over the forecast period.

The personal care packaging industry is broadly categorized into four major segments based on the product type such as skin care, hair care, bath & shower and fragrances. The skin care is considered as one of the fastest growing segment in the market of personal care packaging with substantial revenue generation in the last few years. Growing popularity of the skin care segment is attributed to the growing consumer awareness and high-end demand from for skin care products from Asia-Pacific region. The bath & shower segment has also witnessed substantial growth owing to the growing awareness about health and hygiene among consumers.

The personal care packaging market is divided by region as North America, Europe, Asia-Pacific, Latin America and Africa. North America has shown major growth in recent years owing to the rise in the implementation of latest technologies in packaging sector, increase in the demand for body washes, shower gels, bar and liquid soaps, and existence of well-established industrial infrastructure in the region.

Asia-Pacific region is predicted to hold major market share in the personal care packaging industry with massive growth in forecast period. Countries such as India, China and Singapore are leading the Asia-Pacific market with growing demand for personal care products with lightweight packing, improved living standards, increasing disposable income, and significant investment by leading industry players considering potential growth opportunities in the region.

The key players in the personal care packaging market are Amcor Ltd., Bemis Company, Inc., Mondi plc, Sonoco Products Company, Albea Group AG, Ardagh Group S.A., Ampac Holding and Crown Holdings, Inc., ITC Ltd., and WestRock Co.

Market Segment:

Global Personal Care Packaging Product Outlook (Revenue, USD Million, 2012 – 2022)
  • Flexible
  • Rigid plastics
  • Paper
  • Metal
  • Glass

Monoclonal Antibodies (mAbs) Market Is Burgeoning Worldwide By 2025

The global Monoclonal Antibodies (mAbs) Market is expected to witness a significant CAGR during the forecast period. Monoclonal antibodies (mAbs) are identical by nature since a single type of immune cell is responsible for its production. With almost any substance, monoclonal antibodies could keep attached for any modification. Being an inseparable part of targeted therapy approach for several diseases, various receptors on the cell surface restrain essential functions that are responsible for cell death by various mechanisms. Commercially, many mAbs have helped in modification of autoimmune and chronic disease still date.

The driving factors for monoclonal antibodies market comprise rise in demand for personalized medicine and advances in therapeutic antibodies. In addition, benefits pertaining to use of biologics are likely to stimulate the market development in the near future. By source, the monoclonal antibodies (mAbs) market segmentation includes humanized, chimeric, and murine. By indication, the market is segmented as infectious, inflammatory, vira disease, microbial, and cancer. End-use segmentation for monoclonal antibodies market includes academic institutes, diagnostic laboratories, and hospitals.

Request Sample Copy of This Market Research @

https://www.millioninsights.com/industry-reports/monoclonal-antibodies-mabs-market-size/request-sample

Geographical segmentation for monoclonal (mAbs) market includes North America, South America, Europe, Asia-Pacific, Middle East and Africa. North America accounts for a significant market share owing to rise in government initiatives and R&D activities. Rise in biopharmaceutical manufacturing for quality protein drugs also stimulates the market growth during the forecast period. Asia-Pacific regions have accounted for a greater market in the global scenario due to the presence of geriatric population and prevalence of chronic ailments in geriatric population.

Asia-Pacific regions are likely to grow at a higher rate due to rise in revenue generating drugs and huge availability of patient pool. In addition, rise in R&D activities contribute to the growth of APAC market. The prominent players in the monoclonal antibodies (mAbs) industry include AbbVie, Johnson &Johnson, F.Hoffman-La Roche, Amgen, BMS and Merck.

Global Monoclonal Antibodies Source Type Outlook (Revenue, USD Billion, 2013 – 2024)
• Murine
  • Chimeric
  • Humanized
  • Human

Global Monoclonal Antibodies Production Type Outlook (Revenue, USD Billion, 2013 – 2024)
• In Vivo
• In Vitro

Global Monoclonal Antibodies Indication Outlook (Revenue, USD Billion, 2013 – 2024)
  • Cancer
  • Autoimmune Diseases
  • Inflammatory Diseases
  • Infectious Diseases
  • Microbial Diseases
  • Others

Global Monoclonal Antibodies End-use Outlook (Revenue, USD Billion, 2013 – 2024)
  • Hospitals
  • Research Institutes
  • Others

Neurodiagnostics Market Will Reach Height of USD 18.3 billion By 2025

The factors that propel the growth of the Neurodiagnostics Market include increasing occurrence of neurological disorders such as stroke, growing consciousness among people and technological developments.

The global Neurodiagnostics Market is anticipated to reach at USD 18.3 billion by 2024. Neurodiagnostics are also known as “Neurodiagnostic tests”. They diagnose neurological disorders such as migraine, Parkinson’s disease, stroke, ischemic stroke and epilepsy. The factors that propel the growth of the Neurodiagnostics Market include increasing occurrence of neurological disorders such as stroke, growing consciousness among people and technological developments. On the other hand, there are factors that may hamper the growth of the market including lack of mental health checkup & regular diagnosis in emerging countries. Neurodiagnostics industry is anticipated to grow at a significant CAGR in the upcoming period as the scope, product types, and its applications are increasing across the globe.

Request Sample Copy of This Market Research @

https://www.millioninsights.com/industry-reports/neurodiagnostics-market/request-sample

The market may be explored by product type, end users, technology, and geography. The industry may be explored by product type as intracranial pressure monitor, Electromyography (EMG), Electroencephalogram (EEG), Transcranial Doppler, and Cerebral oximeters. The “Electroencephalogram (EEG)” segment led the Neurodiagnostics Market in 2015 and is anticipated to maintain its dominance by 2024.The key factor that could be attributed to the growth of market includes capacity to efficiently diagnoze epilepsy and the other neurological disorders through non-invasive methods.

Neurodiagnostics industry may be explored by technology as neuroimaging technologies that may further include Nuclear Medicine Imaging (SPECT, PET), Magnetic Resonance Imaging (MRI), Computed Tomography (CT), Electroencephalography (EEG), Near Infrared Spectroscopic Imaging (NIRS), Voxel-based Morphometry (VBM), and Magnetoencephalography (MEG) in vitro diagnostics, and neuroinformatic.

Browse Full Research Report @

https://www.millioninsights.com/industry-reports/neurodiagnostics-market

The “CT and MRI” segment led the neurodiagnostics industry in 2015 and is anticipated to maintain its dominance by 2024.The factors that could be attributed to the growth of the segment might include increasing adoption in the internal body surgeries. The market could be explored based on end users as hospitals, operation theatres, neurophysiological
laboratories and clinics.

North America accounted for the major share of the Neurodiagnostics Market Size in 2015 and will continue to lead in the forecast period. The factors that could be attributed to the growth include increasing acceptance of neurodiagnostics technology.

Some of the key players that fuel the growth of the neurodiagnostics industry comprise Alpha Omega Ltd., Bruker, Guerbet, Agilent Technologies, Fonar Corporation, Doric Lenses, Inc., GE Healthcare, Hitachi Medical Corporation, Hologic Inc., Mightex Systems, NeuroNexus Technologies, Neusoft Medical Systems Co., Ltd., Roche Diagnostics, Plexon, Inc., Philips Healthcare, Siemens Healthcare and Toshiba Medical Systems Corporation. The leading companies are taking up partnerships, mergers and acquisitions, and joint ventures in order to boost the inorganic growth of the industry.

Obesity Treatment Market Will Reach Height of USD 15.6 billion By 2025

Global Obesity Treatment Market is anticipated to reach USD 15.6 billion by 2024. Obesity is a disorder wherein extra body fat gets accumulated to such amount that it may have adverse effects on health. The factors that propel the growth of the obesity treatment market include increasing occurrence of obesity and type 2 diabetes, growing consciousness, and improving healthcare infrastructure in developing market such as China, and India, technological advancement.

On the other hand, there are factors that may hamper the growth of the market including lack of consciousness towards availability of medication, and high cost of medicine. Obesity Treatment industry is anticipated to grow at a significant CAGR in the upcoming period as the scope, product types, and its applications are increasing across the globe. Obesity Treatment industry may be explored by drugs type, application, and geography. The market may be explored by drugs type as Satiety, Appetite Suppressants, Malabsorption, and Combination Drugs. The “combination drugs” segment led the Obesity Treatment Market in 2015 and is anticipated to maintain its dominance by 2024 due to increasing occurrence of obesity and the synergistic result of combination therapy in weight management.

Request Sample Copy of This Market Research @

https://www.millioninsights.com/industry-reports/obesity-treatment-market/request-sample

The market could be explored based on devices and surgery as Endoscopic Procedures, Roux-en-Y, Gastric Bypass, Adjusting Gastric Banding, Sleeve Gastrostomy, Biliopancreatic Diversion with Duodenal Switch, and Others. The “Gastric Bypass” segment led the Obesity Treatment industry in 2015 and is anticipated to maintain its dominance by 2024.

North America accounted for the major share of the Obesity Treatment Market Size in 2015 and will continue to lead in the forecast period. The factors that could be attributed to the growth includes robust government funding and support, technical developments in this region, increase in childhood obesity rates, rising in obese populace, changing lifestyle, surge in membership for health clubs, and heavy R&D funds deployed to change rational and effective obesity treatment procedures. North America is followed by Asia-Pacific region.

Browse Full Research Report @

https://www.millioninsights.com/industry-reports/obesity-treatment-market

Some of the key players that fuel the growth of the Obesity Treatment industry comprise Arena Pharmaceuticals, Inc., VIVUS, Inc., Novo Nordisk A/S, F. Hoffmann-La Roche Ltd., Allergan Plc, Medtronic, Cousin Biotech, Ethicon (subsidiary of Johnson & Johnson), USGI Medical, Inc., and Enter Medics, Inc. The leading companies are taking up partnerships, mergers and acquisitions, and joint ventures in order to boost the inorganic growth of the industry.

Medical Electronics Market Will Generate About USD 219.0 billion By 2025

Global Medical Electronics Market is expected to reach USD 219.0 billion by 2024. Medical Electronics is termed as an instrumentation used in physiological measurement in an area of engineering, medicine discipline, and biology. There are several opportunities for industry and new scientific findings. The future of medical electronics novel biometric appliances, devices, instruments, and systems will be established to treat neurological disorders or chronic diseases and extend life. The Medical Electronics Market is estimated to grow at a significant CAGR of 7.9% over the forecast period as the scope and its applications are rising enormously across the globe.

Rising demand for patient tracking and other monitoring activities, changing lifestyle, growing acceptance of wearable electronics, growth in aging populace and increasing health awareness among populace are documented as major factors of Medical Electronics Market that are estimated to enhance the growth in the years to come.

Request Sample Copy of This Market Research @

https://www.millioninsights.com/industry-reports/medical-electronics-market/request-sample

However, high refurbishment & maintenance cost and strict regulatory policy for product approval are the factors that may restrain overall market growth in the years to come. Medical electronics industry is segmented based on product type, component, application, and region.

Non-invasive and invasive are the product types that could be explored in Medical Electronics in the forecast period. Non-invasive sector comprises monitoring devices and imaging devices. On the other hand, invasive sector comprises endoscopes, pacemakers, gastric electric stimulators, implantable cardioverter- defibrillators (ICDs), spinal cord stimulators, and implantable loop recorders (ILRs). Non-invasive sector accounted for the substantial market share of Medical Electronics and is estimated to lead the overall market in the coming years.

Browse Full Research Report @

https://www.millioninsights.com/industry-reports/medical-electronics-market

Microprocessors/Microcontrollers, Sensors, Displays, Batteries, and Memory Devices are the components that could be explored in Medical Electronics in the forecast period. Batteries sector accounted for the substantial market share of Medical Electronics and is estimated to continue its dominance in the coming years. This may be because of rising adoption of wireless medical devices and growing innovation.

The market may be categorized based on applications like Treatment, Diagnosis, Monitoring and others that could be explored in the forecast period. Monitoring sector accounted for the significant market share of Medical Electronics and is estimated to lead the overall market in the coming years as rising use of home care settings and ambulatory care centers. This may be because of increasing acceptance of telemetry and remote monitoring. The device monitors patients from protracted distance, recommend treatments to patients, and perform intraoperative procedures.

Globally, North America accounted for the substantial market share of Medical Electronics and is estimated to lead the overall market in the coming years. The reason behind the overall market growth could be developed healthcare infrastructure, highly equipped laboratories, rising use of technologically advanced medical device, and high demand for medical electronics in the region.

Instead, Europe and the Asia Pacific are also estimated to have a positive influence on the future growth. Europe is the second largest region with significant market share. However, Asia Pacific is estimated to grow at fastest pace with the highest CAGR in the foremost period. The aspects that may be ascribed to the growth comprise growing population with respiratory diseases, developing healthcare infrastructure, technological enhancement, and rising awareness among populace regarding modern technology and their benefits. The developing countries like India and China are the major consumers of Medical Electronics in the region.

The key players of Medical Electronics Market are Texas Instruments, Philips Healthcare, GE Healthcare, Inc., Siemens Healthcare, STMicroelectronics N.V., Medtronic Plc., NXP Semiconductors N.V., and Analog Devices, Inc. These players are concentrating on inorganic growth to sustain themselves amongst fierce competition. As companies all over the world have to believe that alliance with a market would permit them proportional market existence and authority to declare the leadership position.

Medical Laser Systems Market Set Close To USD 19.22 billion From 2025

Laser medicine consists in the use of lasers in medical diagnosis, treatments, or therapies, such as laser photodynamic therapy, photorejuvenation, and laser surgery.Medical lasers are mainly used for the treatment and diagnosis of medical circumstances and are subject to photochemical, photoablation and photothermal reaction.

The factors that propel the growth of the Medical Laser Systems Market include growing demand for non-invasive and procedures, increasing occurrences of chronic diseases, growing acceptance of advanced laser-based treatments, and rising demand for laser products in diagnosis. On the other hand, there are factors that may hamper the growth of the market including strict safety procedures and high rate of failure. The industry is anticipated to grow at a significant CAGR in the upcoming period as the scope, product types, and its applications are increasing across the globe.

Medical Laser Systems industry may be explored by product type, application, and geography. The market may be explored by product type as Solid Laser System, Diode Laser System, Crystal Laser Systems, and Gas Laser Systems. The “Solid Laser System” segment led the Medical Laser System Market in 2016 and is anticipated to maintain its dominance by 2022 owing to growing application in diagnostic field and technical advances.

Request Sample Copy of This Market Research @

https://www.millioninsights.com/industry-reports/medical-laser-systems-market/request-sample

The key applications that could be explored in the Medical Laser Systems industry include Ophthalmology, Dermatology, Gynecology, Dentistry, Cardiovascular, Urology, and Others (Rheumatology, Gastroenterology, and Traumatology). The “Cardiovascular Diseases” segment led the Medical Laser Systems industry in 2016 and is anticipated to maintain its dominance by 2022 due to increasing occurrence of heart associated diseases and the fast-technological development of cost effective laser-based methods for medical treatment has attributed to the development of this market.

North America accounted for the major share of the Medical Laser Systems Market Size in 2016 and will continue to lead in the forecast period. The factors that could be attributed to the growth includes the increasing occurrences of chronic diseases such as diabetes and obesity. Asia Pacific is the fastest rising region. Development of this region could be attributed to factors such as unmet requirement for medical treatment in emerging economies such as India and China.

Browse Full Research Report @

https://www.millioninsights.com/industry-reports/medical-laser-systems-market Some of the key players that fuel the growth of the Medical Laser System industry comprise AngioDynamics Corp., Alcon Laboratories, Inc., BiolaseInc, American Medical Systems, Inc., Bausch & Lomb Holdings, Lumenis Ltd., Cardiogenesis Corporation, Inc, IRIDEX Corp., Photomedex, Inc., Novadaq Technologies, Inc., Syneron-Candela, and Spectranetics Corporation. The leading companies are taking up partnerships, mergers and acquisitions, and joint ventures in order to boost the inorganic growth of the industry.

Peptide Therapeutics Market Will Reach Height of USD 48.04 billion By 2025

Global Peptide Therapeutics Market is predicted to reach USD 48.04 billion by 2025 owing to rise in demand for efficient & speedy treatment of cancer and other lifestyle-related disorders. Peptides are the naturally occurring biological molecules that are used in drugs to improve the patient’s medical condition. They are highly safe and effective due to which they are widely accepted by physicians and patients for treating several ailments.

In the medical practice, they are ideal for diabetes, infectious diseases, several type of cancers, cardiovascular and other medical conditions. Peptides are highly modifiable and versatile in comparison to other drugs, which make them highly profitable to sponsors. Due to their feature of versatility, they are used in multiple medical conditions that leads to higher penetration of peptide therapeutics industry. Apart from therapeutics effects, the market is also gaining attraction due to comparatively easy marketing approval and familiarity.

Along with the growing prevalence of cardiovascular disorders and cancers, the increasing research & development activities and rich peptide therapeutics pipeline are predicted to support the growth of the market in near future. The patent expiration of various peptide drugs in future is expected to create ample opportunities for the market contributing to its growth at a significant rate.

Request Sample Copy of This Market Research @

https://www.millioninsights.com/industry-reports/peptide-therapeutics-market/request-sample

Peptide therapeutics have application in CNS (Central Nervous System) disorders and respiratory disorders due to features like safe, efficiency and versatility. Advanced research & development facilities and new peptide developments by pharma companies are driving the demand for reasonably priced peptide therapeutics.

Nevertheless, the large scale production of peptide with increasing complexities of peptides is a major challenge for peptide therapeutics market. The development of multifunctional peptides and rise in number of collaboration for the progress of peptide conjugates are currently ruling the market.

Latest advances in peptide synthesis technology is projected to be the key driver for the growth of peptide therapeutics industry. From among the different methods of peptide synthesis, enzymatic and chemical synthesis are important. This technology has integrated structure-activity relationships (SARs) and analog generation to increase bioavailability, increase safety & efficacy of drugs, impart protease resistance, reduce adverse effects, and develop formulations.

Browse Full Research Report @

https://www.millioninsights.com/industry-reports/peptide-therapeutics-market

The other driving factor of the market is the shift towards unexploited market. The market is witnessing several vendors focusing on developing economies due to presence of large population groups and clinical trial subjects. Factors like presence of lenient regulatory guidelines, skilled labor, limited market competition, and low manufacturing costs will encourage vendors to shift their manufacturing processes to the developing economies.

Peptide therapeutics market is categorized on the basis of application, technology, route of administration, molecule type, API peptide type, and geography. On the basis of application, the market is divided into Cancer, Metabolic, CVD, Respiratory, GIT, Anti-infective, Dermatology, CNS, Renal, etc. In terms of route of administration, the market is segmented as Parenteral, Oral, etc.

On the basis of type, peptide therapeutics industry is divided into Innovative and Generic. On the basis of technology, the market is classified into Liquid Phase, Solid Phase, and Hybrid Phase. Type of Molecule is classified into Vasopressin, Somatostatin, Calcitonin, Immunopeptide, Natriuretic, and others. On the basis of API Peptide Type, the market is divided into In-house, and CMO (contract manufacturing organization).

Geographically, peptide therapeutics market is segmented as North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America and Latin America are predicted to hold larger share of the market owing to the rising incidences of cancer and other life-style related disorders.

The key peptide therapeutics industry players comprise AstraZeneca plc, Amgen Inc., Eli Lilly and Company, Sanofi, CordenPharma International GmbH, Teva Pharmaceutical Industries Ltd., Novartis AG, Ipsen S.A., Lonza Group Ltd., Merck & Co. Inc., F. Hoffmann-La Roche AG, Bachem Holding AG, PolyPeptide Group and Novo Nordisk A/S.

Market Segment:

Peptide Therapeutics, Application Outlook (Revenue, USD Million; 2014 – 2025)
• Cancers
  • Metabolic
  • Cardiovascular Disorder
  • Respiratory
  • GIT
  • Antiinfection
  • Pain
  • Dermatology
  • CNS
  • Renal
  • Others

Medical Plastic Market Will Reach Height of USD 33.6 billion By 2025

The global Medical Plastics Market size is expected to value at USD 33.6 billion by 2025. The market is subject to witness a substantial growth due to the growing demand for sterilized plastics form healthcare sector. Implementation and upgradation of infection prevention standards is one of the critical factors responsible for the growth of medical plastics industry of late.

The other factors such as rise in the number of surgical, hospital, and outpatient procedures are expected to boost the market growth over the forecast period. Globally, the medical plastics market is predicted to grow at CAGR of 5.7% in forecast period, providing numerous opportunities for market players to invest in research and development in the market.

Request Sample Copy of This Market Research @

https://www.millioninsights.com/industry-reports/medical-plastics-market/request-sample

However, changes in prices of crude oil are considered as critical factors responsible for variations in the cost of materials like polyvinyl chloride (PVC), polyethylene (PE), polypropylene (PP), and polystyrene, thereby largely affecting market expansion during the forecast period. Additionally, increasing production in the Chinese market is predicted to fuel the price of raw material. Such factors are expected to negatively hamper market growth in the years to come.

Yet, rising healthcare expenditure by local governments and growing preference toward adoption of medical plastic by various clinics and healthcare professionals is predicted to boost market growth in the years to come. Furthermore, rising competition in the market is responsible for the development of innovative products, thus leading to market expansion.

Development of advanced grade plastics and their use in the healthcare sector is predicted to drive the growth of medical plastic industry in near future. Medical plastics are extensively integrated through-out supply chain network in healthcare sector. Growing adoption of the advanced grade plastics in all four stages in the supply chain network including end-use products that are largely utilized used by the governmental clinics, number of medical institutions & facilities, and private clinics, are predicted to amplify the growth of medical plastics market over the forecast period.

Browse Full Research Report @

https://www.millioninsights.com/industry-reports/medical-plastics-market

Rise in the per capita income in both – developed and developing economies is likely to boost demand of the medical plastics in coming years. Medical plastics are known for their enhanced product quality and cost-effectiveness, particularly in comparison with their counterparts, leading to growing demand for the product. Higher production rate and easy availability of medical plastics are expected to drive market demand in next decade. Increasing adoption of thermoforming polypropylene by pharmaceutical companies is attributed to factors such as high strength packaging and higher impact resistance for the packaged products. Other advantages of the thermoforming polypropylene include high durability and sanitization, thus escalating market demand, in the recent years.

The integration of plastic into modern medicine has gradually risen over the past decade. Medical plastics have substantially reduced medicine costs, and pain management. Advanced polymers are increasingly adopted to manufacture new and enhanced artificial limbs. Such polymers are vital for production of plastic disposable delivery devices that are critical in limiting the risk of infection to patients. Medical plastics directly affect patient’s health condition, thus saving more lives with their prolonged use.

The medical plastics industry is divided by region as North America, Europe, Asia-Pacific, Latin America and Africa. North America has shown major growth in recent years owing to the rise in the adoption of the latest technologies in medicine and pharmaceutical sector and existence of well-established healthcare infrastructure. Asia-Pacific region is predicted to hold major market share in the medical plastic market with massive growth in forecast period.

Countries such as India, China, and Japan are leading the Asia-Pacific’s market with rise in the healthcare spending, increase in incidences of lifestyle disorders and diseases, and significant investment by leading industry players considering potential growth opportunities in the region. The key players in the medical plastics industry are Celanese Co., Eastman Chemical Co., Spectrum Plastics Group, Emco Industrial Plastics, Inc., Ensinger GmbH, Connecticut Plastics Co., and Dow Chemical Co.

Market Segment:

Application Outlook (Volume, Kilotons; Revenue, USD Million, 2014 – 2025)
• Medical Device Packaging
• Polyvinyl Chloride
  • Polypropylene
  • PETG
  • HDPE
  • Polystyrene
  • PEEK
  • Others
  • Medical Components
  • Polyvinyl Chloride
  • Polypropylene
  • Polyethylene
  • Polycarbonate
  • PEEK
  • ABS
  • Polystyrene
  • Engineering Plastics
  • Others
  • Orthopedic Implant Packaging
  • Polyvinyl Chloride
  • ABS
  • PETG
  • Polycarbonate
  • Others
  • Orthopedic Soft Goods
  • Polypropylene
  • Silicone
  • ABS
  • Polycarbonate
  • PEEK
  • Engineering Plastics
  • Wound Care
  • Polypropylene
  • Thermoplastic Polyurethanes
  • Others
  • Cleanroom Supplies
  • Polyvinyl Chloride
  • Polypropylene
  • PETG
  • Polycarbonate
  • PEEK
  • ABS
  • Polystyrene
  • Engineering Plastics
  • Others
  • BioPharma Devices
  • Polycarbonate
  • Silicone
  • Engineering plastic
  • Others
  • Mobility Aids
  • ABS
  • Polycarbonate
  • PEEK
  • Engineering plastic
  • Sterilization and Infection Prevention
  • Polypropylene
  • Silicone
  • ABS
  • Polycarbonate
  • PEEK
  • Engineering plastic
  • Tooth Implants
  • Polycarbonate
  • PEEK
  • Others
  • Denture Base Material
  • PMMA
  • Polycarbonate
  • Polyamide
  • Others
  • Other Implants
  • Polypropylene
  • Silicone
  • Polycarbonate
  • PEEK
  • Engineering Plastics
  • Others
  • Polyvinyl Chloride
  • Polypropylene
  • Polystyrene
  • Silicone
  • ABS
  • Polycarbonate
  • PEEK
  • Engineering plastic

Glycobiology Market Is Burgeoning Worldwide By 2025

Glycomics is a wide and emerging scientific field emphasizing on defining functional aspects of glycans in biological systems. The higher the complexity of glycome, which is defined as the range of glycans particularly in a cell or organism leads to multiple challenges that could be subjectively decoded.

Glycobiology is the study of the structure, function and biology of carbohydrates, also called glycans. Glycans are present in every living organism. Glycobiology is a rapidly growing field in biology, with relevance to biomedicine, biotechnology and basic research.

The global Glycomics/Glycobiology Market is expected to grow at a CAGR of 14.4% in the forthcoming period. Glycomics is a wide and emerging scientific field emphasizing on defining functional aspects of glycans in biological systems. The higher the complexity of glycome, which is defined as the range of glycans particularly in a cell or organism leads to multiple challenges that could be subjectively decoded.

The challenges are resolved with progress in mass spectrometry along with expansion of genetic and cell biology studies. On the contrary, determining a specific glycan and glycan-binding proteins by incorporating new technology of glycan microarrays guide the glycan function.

Request Sample Copy of This Market Research @

https://www.millioninsights.com/industry-reports/glycomics-glycobiology-market/request-sample

Glycomics/glycobiology industry is driven by factors such as growing investments for R&D with a strong emphasis of pharmaceutical and biotechnology companies on innovative product development. Rise in development of new vaccines for genetic diseases comprising diabetes and influenza will add to the market growth in the forecast period. Rise in government funding for R&D activities and novel approach for drug production process are the other factors driving the market.

Product segmentation for glycomics market includes enzymes, reagents, kits and instruments. Enzymes are further quad furcated into glycosyltransferases, neuraminidases, sialyl transferases and glycosidases. Enzyme segment accounts for a high market share due to wide applications for various drug recovery procedures. Application segment for glycomics/glycobiology industry includes drug discovery &development diagnostics.

Regional segmentation for glycomics/glycobiology market includes North America, Latin America, Europe, Asia-Pacific, Middle East and Africa. North America dominates the market due to high revenue share and presence of large pharmaceutical & biotechnology firms. Presence of developed healthcare infrastructure and availability of advanced products in these regions is likely to promote the market growth.

Browse Full Research Report @

https://www.millioninsights.com/industry-reports/glycomics-glycobiology-market

Asia-Pacific’s glycobiology industry is estimated to grow at a higher CAGR in the forecast period due to booming healthcare infrastructure in emerging economies. Availability of large pool of patients and low cost of clinical trials and accessibility of skilled personnel have propelled the market growth in Asia-Pacific’s market. The key players in the glycomics/glycobiology market include Thermo Fisher Scientific Inc, Agilent Technologies, Bruker, Merck KGaA, Shimazdu Corp, New England Biolabs, Waters Corporation, and Takara Bio Inc.

Market Segment:

Glycomics/Glycobiology Product Outlook (Revenue, USD Million, 2014 – 2025)
• Instruments
      • Mass Spectrometers
      • HPLC
      • MALDI-TOF
      • Array Systems
      • Others
  • Reagents
      • Glycoproteins
      • Monosaccharides
      • Oligosaccharides
      • Others
  • Kits
      • Glycan Labeling Kits
      • Glycan Purification Kits
      • Glycan Release Kits
      • Others
  • Enzymes
      • Glycosidases
      • Glycosyltransferases
      • Neuraminidases
      • Sialyltransferases
      • Others

Glycomics/Glycobiology Application Outlook (Revenue, USD Million, 2014 – 2025)
  • Drug Discovery & Development
  • Diagnostics
  • OthersGlycomics/Glycobiology End-Use Outlook (Revenue, USD Million, 2014 – 2025)
  • Academic & Research Institutes
  • Pharmaceutical & Biotechnology Companies
  • CROs

Drug of Abuse Testing Services Market Will Reach Height of USD 2.9 billion By 2025

What is a Drug of Abuse Testing?

Drugs of abuse testing implies discovery of one or more prescribed or illegal substances in the blood, urine, hair, sweat, saliva. The procedure is carried out with the help of several methods like Chromatography, Rapid Testing, and Immunoassays Analyzers. Immunoassays Analyzers is the equipment that supports biochemical tests to sense substances or quantify specific proteins. The procedure takes place with the support of antibodies or antigens that perform the test.

The factors that propel the growth of the Drug of Abuse Testing Services industry include new product & service launches, enforcement of stringent laws mandating drug and alcohol testing, and regulatory approvals, and increasing consumption of drugs & alcohol. On the other hand, there are factors that may hamper the development of the market; including growing drug-related mortality, growing demand for drug of abuse treatment, and rising government entities. Drugs of Abuse Testing Services Market is anticipated to grow at a significant CAGR in the forthcoming period as the scope, product types, and its applications are increasing across the globe.

The market could be explored by sample type, testing type, drug type, end user, and geography. Drugs of Abuse Testing Services industry may be analyzed by sample type as Saliva, Breath, Urine, Blood, and Hair and Sweat. The “Urine” segment led the market in 2016 and is anticipated to maintain its dominance by 2025.

Request Sample Copy of This Market Research @

https://www.millioninsights.com/industry-reports/drugs-abuse-testing-services-market/request-sample

Drug of Abuse Testing Services Market may be explored by Testing Type as Work Place Screening, Criminal Justice Testing, and Pain Management Testing. The “Workplace Testing” segment led the market in 2016 and is anticipated to maintain its dominance by 2025 owing to increasing safety concerns in the workplace coupled with compulsion of drug screening. Drug of Abuse Testing Services industry may be analyzed by drug type as Cannabis, Alcohol, Cocaine, Opioids, LSD, and Amphetamine. The industry may be analyzed by end user as Diagnostic laboratories, Hospitals, Forensic Laboratories, and On-the-spot Testing.

North America accounted for the major share of the Drug of Abuse Testing Services Market Size in 2016 and will continue to lead in the forecast period. The factors that could be attributed to the growth include increasing demand for rapid testing devices in North America and improved use of drug testing facilities in investigational procedures. North America is followed by Europe.

Browse Full Research Report @

https://www.millioninsights.com/industry-reports/drugs-abuse-testing-services-market

Some of the key players that fuel the growth of the Drug of Abuse Testing Services industry comprise Siemens Healthineers, Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., F. Laboratory Corporation of America Holdings, Drägerwerk AG & Co. KGaA, Abbott Laboratories, and Danaher Corporation (Beckman Coulter, Inc). The leading companies are taking up partnerships, mergers and acquisitions, and joint ventures in order to boost the inorganic growth of the industry.

Market Segment:Drug Type Outlook (Revenue, USD Million, 2014 – 2025)
• Alcohol
  • Cannabis
  • Cocaine
  • Opioids
  • Amphetamine
  • LSD